Results 1 to 10 of about 244,798 (144)

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Annals of the Rheumatic Diseases, 2023
Objectives To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods An international Task Force formed the questions for the systematic literature reviews (January 2018–December ...
A. Fanouriakis, M. Kostopoulou, Jeanette Andersen, M. Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, I. Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, R. Furie, D. Gladman, F. Houssiau, L. Inês, D. Jayne, M. Kouloumas, László Kovács, C. Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, J. Mucke, C. Mukhtyar, György Nagy, S. Navarra, Ioannis Parodis, J. Pego-Reigosa, M. Petri, Bernardo A Pons-Estel, M. Schneider, J. Smolen, E. Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y. Teng, A. Tincani, E. Vital, RF van Vollenhoven, Chris Wincup, G. Bertsias, Dimitrios T Boumpas   +41 more
semanticscholar   +1 more source

Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

Brain Sciences, 2021
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies.
Alba Jerez-Lienas, Alexis Mathian, Jenifer Aboab, Isabelle Crassard, Miguel Hie, Fleur Cohen-Aubart, Julien Haroche, Denis Wahl, Ricard Cervera, Zahir Amoura   +9 more
doaj   +1 more source

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis & Rheumatology, 2022
To assess the efficacy and safety of deucravacitinib, an oral, selective, allosteric inhibitor of TYK2, in a phase II trial in adult patients with active systemic lupus erythematosus (SLE).
Eric F Morand, M. Pike, J. Merrill, R. V. van Vollenhoven, V. Werth, C. Hobar, N. Delev, V. Shah, B. Sharkey, T. Wegman, I. Catlett, Subhashish Banerjee, S. Singhal   +12 more
semanticscholar   +1 more source

Systemic lupus erythematosus with trisomy X: a case report and review of the literature

Journal of Medical Case Reports, 2022
Background The cause of systemic lupus erythematosus is not completely clear so far, but the prevalence of systemic lupus erythematosus is significantly increased in people with additional X chromosomes.
Fang Luo, Qiao Ye, Jie Shen
doaj   +1 more source

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Arthritis & Rheumatology, 2019
To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
M. Aringer, K. Costenbader, D. Daikh, R. Brinks, M. Mosca, R. Ramsey‐Goldman, J. Smolen, D. Wofsy, D. Boumpas, D. Kamen, D. Jayne, R. Cervera, N. Costedoat-Chalumeau, B. Diamond, D. Gladman, B. Hahn, F. Hiepe, S. Jacobsen, D. Khanna, K. Lerstrøm, E. Massarotti, Joseph Mccune, G. Ruiz‐Irastorza, J. Sánchez-Guerrero, Matthias Schneider, M. Urowitz, G. Bertsias, B. Hoyer, N. Leuchten, C. Tani, S. Tedeschi, Z. Touma, G. Schmajuk, B. Anić, F. Assan, T. Chan, A. Clarke, M. Crow, L. Czirják, A. Doria, W. Graninger, Bernadett Halda-Kiss, S. Hasni, P. Izmirly, M. Jung, G. Kumánovics, X. Mariette, I. Padjen, J. Pego-Reigosa, J. Romero-Díaz, Íñigo Rúa-Figueroa Fernández, R. Seror, G. Stummvoll, Yoshiya Tanaka, M. Tektonidou, C. Vasconcelos, E. Vital, D. Wallace, Ş. Yavuz, Marcus John Beasley, M. Fritzler, R. Naden, T. Dörner, S. Johnson   +63 more
semanticscholar   +2 more sources

Peritonitis as the first presentation of systemic lupus erythematous: a case report

Journal of Medical Case Reports, 2021
Background Systemic lupus erythematosus is an inflammatory disease affecting several organs. Serositis is one of the systemic lupus erythematosus presentations, but peritonitis is a relatively rare presentation.
Zahedin Kheyri, Amirreza Laripour, Moein Ala   +2 more
doaj   +1 more source

Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination

Arthritis & Rheumatology, 2021
To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE).
P. Izmirly, Mimi Y. Kim, M. Samanovic, R. Fernandez-Ruiz, Sharon Ohana, Kristina K Deonaraine, Alexis J Engel, M. Masson, Xianhong Xie, A. Cornelius, R. Herati, Rebecca H. Haberman, J. Scher, Allison Guttmann, R. Blank, B. Plotz, M. Haj-Ali, Brittany Banbury, Sara Stream, Ghadeer Hasan, Gary H. Ho, P. Rackoff, Ashira Blazer, C. Tseng, H. M. Belmont, A. Saxena, M. Mulligan, R. Clancy, J. Buyon   +28 more
semanticscholar   +1 more source

ASSESSMENT OF THE CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: CHOOSING THE APPROPRIATE TOOL

Arta Medica, 2020
Objectives. The aim of the research was to assess the cardiovascular risk in patients with systemic lupus erythematosus (SLE). Materials and Methods.
Victoria Sadovici-Bobeică, Lucia Mazur-Nicorici, Natalia Loghin-Oprea, Maria Garabajiu, Virginia Șalaru, Minodora Mazur   +5 more
doaj   +1 more source

Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries

Arthritis & Rheumatology, 2021
Epidemiologic data on systemic lupus erythematosus (SLE) are limited, particularly for racial/ethnic subpopulations in the US. This meta‐analysis leveraged data from the Centers for Disease Control and Prevention (CDC) National Lupus Registry network of ...
P. Izmirly, Hilary B. Parton, Lu Wang, W. McCune, S. S. Lim, Cristina Drenkard, E. Ferucci, M. Dall'Era, Caroline Gordon, Charles G. Helmick, E. Somers   +10 more
semanticscholar   +1 more source

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Arthritis & Rheumatism, 2012
OBJECTIVE The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet ...
M. Petri, A. Orbai, Graciela S. Alarcón, C. Gordon, Joan T. Merrill, P. Fortin, I. Bruce, D. Isenberg, Daniel J. Wallace, O. Nived, G. Sturfelt, R. Ramsey‐Goldman, S. Bae, J. Hanly, J. Sánchez-Guerrero, A. Clarke, C. Aranow, S. Manzi, M. Urowitz, D. Gladman, K. Kalunian, M. Costner, Victoria P. Werth, A. Zoma, S. Bernatsky, G. Ruiz-Irastorza, M. Khamashta, S. Jacobsen, Jill P. Buyon, P. Maddison, M. Dooley, Ronald F van Vollenhoven, E. Ginzler, T. Stoll, C. Peschken, J. Jorizzo, Jeffrey P Callen, S. S. Lim, B. Fessler, M. Inanç, D. Kamen, Anisur Rahman, K. Steinsson, Andrew G. Franks, L. Sigler, S. Hameed, H. Fang, N. Pham, R. Brey, M. H. Weisman, G. McGwin, Laurence S Magder   +51 more
semanticscholar   +1 more source